Skip Header

1 - 25 of 45 results for author:"Morser J." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (10)

Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.

Yamaguchi Y., Shao Z., Sharif S., Du X.Y., Myles T., Merchant M., Harsh G., Glantz M., Recht L., Morser J. et al.

J. Biol. Chem. 288:3097-3111(2013) · Mapped (16)

Thrombomodulin links coagulation to inflammation and immunity.

Morser J.

Curr Drug Targets 13:421-431(2012) · Mapped (2)

Development and preclinical efficacy of novel transforming growth factor-beta1 short interfering RNAs for pulmonary fibrosis.

D'Alessandro-Gabazza C.N., Kobayashi T., Boveda-Ruiz D., Takagi T., Toda M., Gil-Bernabe P., Miyake Y., Yasukawa A., Matsuda Y., Suzuki N. et al.

Am. J. Respir. Cell Mol. Biol. 46:397-406(2012) · Mapped (9)

Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma.

Yamaguchi Y., Du X.Y., Zhao L., Morser J., Leung L.L.

J. Biol. Chem. 286:39510-39519(2011) · Mapped (1)

Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma.

Zhao L., Yamaguchi Y., Sharif S., Du X.Y., Song J.J., Lee D.M., Recht L.D., Robinson W.H., Morser J., Leung L.L.

J. Biol. Chem. 286:39520-39527(2011) · Mapped (1)

Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis.

Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis (CLEAR) Registry
Song J.J., Hwang I., Cho K.H., Garcia M.A., Kim A.J., Wang T.H., Lindstrom T.M., Lee A.T., Nishimura T., Zhao L. et al.

J. Clin. Invest. 121:3517-3527(2011) · Mapped (14)

Atherosclerosis amelioration by moderate alcohol consumption is associated with increased circulating levels of stromal cell-derived factor-1.

Gil-Bernabe P., Boveda-Ruiz D., D'Alessandro-Gabazza C., Toda M., Miyake Y., Mifuji-Moroka R., Iwasa M., Morser J., Gabazza E.C., Takei Y.

Circ. J. 75:2269-2279(2011) · Mapped (2)

High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice.

Beppu T., Gil-Bernabe P., Boveda-Ruiz D., D'Alessandro-Gabazza C., Matsuda Y., Toda M., Miyake Y., Shiraki K., Murata M., Murata T. et al.

J. Thromb. Haemost. 8:2514-2522(2010) · Mapped (10)

Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells.

Takagi T., Taguchi O., Toda M., Ruiz D.B., Bernabe P.G., D'Alessandro-Gabazza C.N., Miyake Y., Kobayashi T., Aoki S., Chiba F. et al.

Am. J. Respir. Crit. Care Med. 183:31-42(2011) · Mapped (2)

Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Dua M.M., Miyama N., Azuma J., Schultz G.M., Sho M., Morser J., Dalman R.L.

Surgery 148:429-435(2010) · Mapped (5)

Enhanced abdominal aortic aneurysm formation in thrombin-activatable procarboxypeptidase B-deficient mice.

Schultz G., Tedesco M.M., Sho E., Nishimura T., Sharif S., Du X., Myles T., Morser J., Dalman R.L., Leung L.L.

Arterioscler. Thromb. Vasc. Biol. 30:1363-1370(2010) · Mapped (15)

Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.

Qin L., D'Alessandro-Gabazza C.N., Aoki S., Gil-Bernabe P., Yano Y., Takagi T., Boveda-Ruiz D., Ramirez Marmol A.Y., San Martin Montenegro V.T., Toda M. et al.

J. Thromb. Haemost. 8:808-816(2010) · Mapped (1)

Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis.

Sharif S.A., Du X., Myles T., Song J.J., Price E., Lee D.M., Goodman S.B., Nagashima M., Morser J., Robinson W.H. et al.

Arthritis Rheum. 60:2902-2912(2009) · Mapped (8)

Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.

Scotton C.J., Krupiczojc M.A., Konigshoff M., Mercer P.F., Lee Y.C., Kaminski N., Morser J., Post J.M., Maher T.M., Nicholson A.G. et al.

J. Clin. Invest. 119:2550-2563(2009) · Mapped (9)

The coagulation and protein C pathways in patients with sleep apnea.

Takagi T., Morser J., Gabazza E.C., Qin L., Fujiwara A., Naito M., Yamaguchi A., Kobayashi T., D'Alessandro-Gabazza C.N., Boveda Ruiz D. et al.

Lung 187:209-213(2009) · Mapped (20)

The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex.

Wu C., Kim P.Y., Manuel R., Seto M., Whitlow M., Nagashima M., Morser J., Gils A., Declerck P., Nesheim M.E.

J. Biol. Chem. 284:7059-7067(2009) · Mapped (10)

Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.

Bruno N.E., Yano Y., Takei Y., Qin L., Suzuki T., Morser J., D'Alessandro-Gabazza C.N., Mizoguchi A., Suzuki K., Taguchi O. et al.

Thromb. Haemost. 100:90-100(2008) · Mapped (2)

Structures of potent selective peptide mimetics bound to carboxypeptidase B.

Adler M., Buckman B., Bryant J., Chang Z., Chu K., Emayan K., Hrvatin P., Islam I., Morser J., Sukovich D. et al.

Acta Crystallogr. D Biol. Crystallogr. 64:149-157(2008) · Mapped (1)

Protective role of thrombin activatable fibrinolysis inhibitor in obstructive nephropathy-associated tubulointerstitial fibrosis.

Bruno N.E., Yano Y., Takei Y., Gabazza E.C., Qin L., Nagashima M., Morser J., D'Alessandro-Gabazza C.N., Taguchi O., Sumida Y.

J. Thromb. Haemost. 6:139-146(2008) · Mapped (5)

Thiophene-anthranilamides as highly potent and orally available factor Xa inhibitors.

Ye B., Arnaiz D.O., Chou Y.L., Griedel B.D., Karanjawala R., Lee W., Morrissey M.M., Sacchi K.L., Sakata S.T., Shaw K.J. et al.

J. Med. Chem. 50:2967-2980(2007) · Mapped (1)

Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.

Fujimoto H., Gabazza E.C., Taguchi O., Nishii Y., Nakahara H., Bruno N.E., D'Alessandro-Gabazza C.N., Kasper M., Yano Y., Nagashima M. et al.

Am. J. Pathol. 168:1086-1096(2006) · Mapped (1)

15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.

Migita H., Morser J.

Arterioscler. Thromb. Vasc. Biol. 25:710-716(2005) · Mapped (3)

Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.

Chan J.C., Knudson O., Wu F., Morser J., Dole W.P., Wu Q.

Proc. Natl. Acad. Sci. U.S.A. 102:785-790(2005) · UniProtKB (2) · Mapped (4)

Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.

Gu J.M., Johns A., Morser J., Dole W.P., Greaves D.R., Deng G.G.

J. Cell. Physiol. 204:73-82(2005) · Mapped (3)

Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling.

Festoff B.W., Ameenuddin S., Santacruz K., Morser J., Suo Z., Arnold P.M., Stricker K.E., Citron B.A.

J. Neurotrauma 21:907-922(2004) · Mapped (2)

to top of page·

Page of 2 | Next »